West Pharmaceutical Services (WST) Competitors

$299.28 -3.12 (-1.03%)

As of 10:23 AM Eastern

WST vs. CHE, EHC, ALGN, COO, and MMSI

Should you buy West Pharmaceutical Services stock or one of its competitors? MarketBeat compares West Pharmaceutical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with West Pharmaceutical Services include Chemed (CHE), Encompass Health (EHC), Align Technology (ALGN), Cooper Companies (COO), and Merit Medical Systems (MMSI). These companies are all part of the "medical" sector.

How does West Pharmaceutical Services compare to Chemed?

West Pharmaceutical Services (NYSE:WST) and Chemed (NYSE:CHE) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

West Pharmaceutical Services presently has a consensus price target of $322.89, suggesting a potential upside of 7.70%. Chemed has a consensus price target of $501.50, suggesting a potential upside of 18.07%. Given Chemed's higher probable upside, analysts plainly believe Chemed is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

West Pharmaceutical Services has a net margin of 16.85% compared to Chemed's net margin of 10.23%. Chemed's return on equity of 27.18% beat West Pharmaceutical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Chemed	10.23%	27.18%	17.38%

West Pharmaceutical Services has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Chemed has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

West Pharmaceutical Services has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	6.89	$493.70M	$7.48	40.08
Chemed	$2.53B	2.23	$265.24M	$18.35	23.15

In the previous week, Chemed had 3 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 6 mentions for Chemed and 3 mentions for West Pharmaceutical Services. Chemed's average media sentiment score of 0.69 beat West Pharmaceutical Services' score of 0.60 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Chemed pays an annual dividend of $2.40 per share and has a dividend yield of 0.6%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Chemed pays out 13.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years. Chemed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

West Pharmaceutical Services and Chemed tied by winning 10 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Encompass Health?

West Pharmaceutical Services (NYSE:WST) and Encompass Health (NYSE:EHC) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Encompass Health has higher revenue and earnings than West Pharmaceutical Services. Encompass Health is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	6.89	$493.70M	$7.48	40.08
Encompass Health	$5.94B	1.79	$566.20M	$5.99	17.88

In the previous week, Encompass Health had 7 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 10 mentions for Encompass Health and 3 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.60 beat Encompass Health's score of 0.31 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Encompass Health	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

West Pharmaceutical Services presently has a consensus target price of $322.89, suggesting a potential upside of 7.70%. Encompass Health has a consensus target price of $144.17, suggesting a potential upside of 34.57%. Given Encompass Health's stronger consensus rating and higher possible upside, analysts clearly believe Encompass Health is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75
Encompass Health	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.11

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.7%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Encompass Health pays out 12.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has raised its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

West Pharmaceutical Services has a net margin of 16.85% compared to Encompass Health's net margin of 10.04%. West Pharmaceutical Services' return on equity of 19.03% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Encompass Health	10.04%	18.28%	8.27%

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 1.8% of Encompass Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

West Pharmaceutical Services has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

Summary

West Pharmaceutical Services and Encompass Health tied by winning 10 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Align Technology?

Align Technology (NASDAQ:ALGN) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Align Technology currently has a consensus target price of $205.85, suggesting a potential upside of 27.62%. West Pharmaceutical Services has a consensus target price of $322.89, suggesting a potential upside of 7.70%. Given Align Technology's higher probable upside, equities analysts clearly believe Align Technology is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.57
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

West Pharmaceutical Services has a net margin of 16.85% compared to Align Technology's net margin of 10.50%. West Pharmaceutical Services' return on equity of 19.03% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
West Pharmaceutical Services	16.85%	19.03%	14.06%

West Pharmaceutical Services has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.86	$410.35M	$5.96	27.06
West Pharmaceutical Services	$3.07B	6.89	$493.70M	$7.48	40.08

In the previous week, Align Technology had 5 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 8 mentions for Align Technology and 3 mentions for West Pharmaceutical Services. Align Technology's average media sentiment score of 1.10 beat West Pharmaceutical Services' score of 0.60 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Align Technology has a beta of 1.7, indicating that its share price is 70% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market.

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

West Pharmaceutical Services beats Align Technology on 10 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

In the previous week, Cooper Companies had 8 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 11 mentions for Cooper Companies and 3 mentions for West Pharmaceutical Services. Cooper Companies' average media sentiment score of 1.08 beat West Pharmaceutical Services' score of 0.60 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	6 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

West Pharmaceutical Services has a net margin of 16.85% compared to Cooper Companies' net margin of 9.67%. West Pharmaceutical Services' return on equity of 19.03% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	9.67%	10.34%	6.93%
West Pharmaceutical Services	16.85%	19.03%	14.06%

Cooper Companies currently has a consensus target price of $90.79, suggesting a potential upside of 50.48%. West Pharmaceutical Services has a consensus target price of $322.89, suggesting a potential upside of 7.70%. Given Cooper Companies' higher probable upside, research analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	2.88	$374.90M	$2.02	29.87
West Pharmaceutical Services	$3.07B	6.89	$493.70M	$7.48	40.08

Cooper Companies has a beta of 0.89, suggesting that its stock price is 11% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

Summary

West Pharmaceutical Services beats Cooper Companies on 10 of the 16 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

West Pharmaceutical Services has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.54B	2.40	$128.49M	$2.31	26.90
West Pharmaceutical Services	$3.07B	6.89	$493.70M	$7.48	40.08

West Pharmaceutical Services has a net margin of 16.85% compared to Merit Medical Systems' net margin of 9.03%. West Pharmaceutical Services' return on equity of 19.03% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
West Pharmaceutical Services	16.85%	19.03%	14.06%

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Merit Medical Systems currently has a consensus target price of $92.80, suggesting a potential upside of 49.35%. West Pharmaceutical Services has a consensus target price of $322.89, suggesting a potential upside of 7.70%. Given Merit Medical Systems' higher probable upside, research analysts clearly believe Merit Medical Systems is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Merit Medical Systems had 9 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 12 mentions for Merit Medical Systems and 3 mentions for West Pharmaceutical Services. Merit Medical Systems' average media sentiment score of 1.03 beat West Pharmaceutical Services' score of 0.60 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Merit Medical Systems has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

Summary

West Pharmaceutical Services beats Merit Medical Systems on 11 of the 17 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WST vs. The Competition

Export

Metric	West Pharmaceutical Services	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$21.12B	$14.76B	$6.31B	$22.97B
Dividend Yield	0.28%	2.08%	2.79%	4.07%
P/E Ratio	39.96	17.30	21.03	28.29
Price / Sales	6.89	2.12	551.42	24.60
Price / Cash	32.05	12.42	42.94	25.11
Price / Book	7.08	2.95	9.76	4.73
Net Income	$493.70M	$534.24M	$3.55B	$1.07B
7 Day Performance	-7.02%	1.96%	-0.53%	-1.11%
1 Month Performance	11.94%	-1.51%	1.20%	1.36%
1 Year Performance	44.29%	-4.66%	41.21%	24.41%

West Pharmaceutical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WST West Pharmaceutical Services	4.071 of 5 stars	$299.28 -1.0%	$322.89 +7.9%	+40.0%	$21.24B	$3.07B	40.19	10,800	Gap Up
CHE Chemed	4.2974 of 5 stars	$421.41 -0.7%	$501.50 +19.0%	-24.0%	$5.63B	$2.53B	22.97	15,811
EHC Encompass Health	4.3985 of 5 stars	$104.94 -1.1%	$144.17 +37.4%	-8.9%	$10.53B	$5.94B	17.52	42,000	Dividend Announcement
ALGN Align Technology	4.1662 of 5 stars	$164.61 -2.5%	$205.85 +25.1%	-15.1%	$12.09B	$4.03B	27.62	20,290	Positive News
COO Cooper Companies	4.2232 of 5 stars	$58.98 -1.7%	$90.79 +53.9%	-27.3%	$11.71B	$4.09B	29.20	15,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WST) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, ALGN, COO, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, ALGN, COO, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Do analysts rate WST or CHE?

Do institutionals & insiders believe in WST or CHE?

Is WST or CHE more profitable?

Which has more volatility & risk, WST or CHE?

Which has preferable earnings & valuation, WST or CHE?

Does the media refer more to WST or CHE?

Is WST or CHE a better dividend stock?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Which has better valuation & earnings, WST or EHC?

Does the media prefer WST or EHC?

Do analysts rate WST or EHC?

Is WST or EHC a better dividend stock?

Is WST or EHC more profitable?

Do institutionals and insiders believe in WST or EHC?

Which has more risk and volatility, WST or EHC?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Do analysts prefer ALGN or WST?

Is ALGN or WST more profitable?

Which has higher earnings and valuation, ALGN or WST?

Does the media refer more to ALGN or WST?

Which has more risk & volatility, ALGN or WST?

Do institutionals & insiders hold more shares of ALGN or WST?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Does the media prefer COO or WST?

Do insiders and institutionals hold more shares of COO or WST?

Is COO or WST more profitable?

Do analysts prefer COO or WST?

Which has stronger valuation & earnings, COO or WST?

Which has more volatility and risk, COO or WST?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Which has stronger valuation & earnings, MMSI or WST?

Is MMSI or WST more profitable?

Do insiders and institutionals hold more shares of MMSI or WST?

Do analysts prefer MMSI or WST?

Does the media prefer MMSI or WST?

Which has more volatility and risk, MMSI or WST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools